相关实验视频
Updated: May 30, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.4K
支气管炎的严重程度影响血液计数和炎症标志物水平:现实生活经验
Antonella Gambadauro1, Salvatore Mollica1, Emanuela Rosa2
1Pediatric Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Via Consolare Valeria 1, 98124 Messina, Italy.
Viruses
|January 25, 2025
概括
一个新的指数,RBC/AiW/1000,在预测婴儿支气管炎的严重程度方面显示出希望. 这种来自血液细胞计数的标志物可以帮助早期评估下呼吸道感染的风险.
科学领域:
- 儿童传染病 儿童传染病
- 血液学 血液学 血液学
- 临床生物标志物 临床生物标志物
背景情况:
- 支气管炎是婴儿下呼吸道感染 (LRTI) 的主要原因之一.
- 在入院时预测支气管炎的严重程度对于及时干预至关重要.
- 现有的炎症标志物可能无法完全捕捉疾病的严重程度.
研究的目的:
- 研究完整血清 (CBC),C反应蛋白 (CRP) 和新型炎症指数与支气管炎严重程度之间的关联.
- 确定患有支气管炎的住院婴儿严重后果的潜在预测标志物.
主要方法:
- 追溯分析了95名因支气管炎住院的婴儿的数据.
- 对五个严重性结局的评估:BRAS,PICU入院,呼吸器支持,静脉补水和停留时间 (LOS).
- 对CBC参数和各种炎症指数 (NLR,PLR,MLR等) 的评估. ) 的情况.
主要成果:
- 较低的年龄和入院时的体重与严重性结果的增加相关.
- 长时间的LOS (≥6天) 与白细胞,淋巴细胞和乙酸细胞的升高有关.
- 一个新的指数,RBC/AiW/1000,在超过350时,与所有分析的严重性结果显示出具有统计学意义的关联.
结论:
- 对CBC,CRP和炎症指数进行了全面的分析,以预测支气管炎的严重程度.
- 新型指数RBC/AiW/1000成为患有支气管炎的婴儿疾病严重程度的潜在预测标志物.
- 进一步验证RBC/AiW/1000可能会提高儿童支气管炎的早期风险分层和管理.
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Pneumonia II: Pathophysiology
211
The pathophysiology of pneumonia involves the following steps:
211
Drugs Used in Lower Respiratory Disorders: Overview
347
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
347
Pneumonia III: Complications and Assessment
151
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
151
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K

